IGHE and ancylostomiasis: Na-ASP-2 was progressed to Phase I clinical trials; however, vaccination of volunteers in Brazil (where N. americanus is endemic) resulted in generalised urticarial reactions in several volunteers, thought to be associated with preexisting Na-ASP-2-specific IgE induced by previous hookworm infection [29].